Medicaid

First Opinion By Constantinos Michaelidis and Candra Szymanski

Home care instead of hospital care: Congress should extend a crucial waiver

First Opinion By Amol Navathe, Risa Lavizzo-Mourey and Joshua Liao

How to fix the two-tier U.S. health payment system

First Opinion By Ge Bai and David A. Hyman

Nonprofit hospitals’ community benefits should square with their tax exemptions. They often don’t

Pharmalot By Ed Silverman

A looming decision on Medicare coverage for Biogen’s Alzheimer’s drug could shock state Medicaid programs

First Opinion By Aytan Y. Bellin

My aunt’s ‘Kafkaesque journey’ to get the home care she needs

Pharmalot By Ed Silverman

Biogen’s new Alzheimer’s drug could cost Medicaid up to $2.2 billion a year

Pharmalot By Ed Silverman

Centene to pay $143 million to two states to settle allegations of overcharging Medicaid

Politics By Rachel Cohrs

Biden’s Medicaid pressure tactics could put his team at odds with hospitals

Exclusive By Rachel Cohrs and Lev Facher

Top Senate Republican holds up Biden’s CMS nominee over Texas Medicaid waiver

Pharmalot By Ed Silverman

Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time

Pharmalot By Ed Silverman

Tennessee to become the first state to run a closed Medicaid drug formulary

First Opinion By Andrey Ostrovsky

Advice for the next CMS administrator’s first 100 days

First Opinion By Michael Hochman and Michelle Levander

Create a scorecard to help make safety-net providers accountable to patients and the public

First Opinion By Eric Letsinger and Alison Rein

Invest in community-based organizations to put health dollars where they are really needed

STAT+ Conversations By Casey Ross

‘I can’t imagine going back’: Medicare leader calls for expanded telehealth access after Covid-19

Pharmalot By Ed Silverman

Mallinckrodt loses a court case and is on the hook for $650 million in overdue Medicaid rebates

First Opinion By Eric Schneider

Super Tuesday results suggest that Americans ‘aren’t looking for big structural changes’ in health care

First Opinion By Wendy E. Parmet

Trump’s immigration policies will make the coronavirus pandemic worse

Pharmalot By Ed Silverman

Justice Department sues Mallinckrodt over ‘hundreds of millions of dollars’ in Medicaid rebates

Pharmalot By Ed Silverman

PBMs favor their own pharmacies in the Florida Medicaid program

Pharmalot By Ed Silverman

U.S. officials will let Novartis pay expenses for some Kymriah patients who must travel for treatment

First Opinion By Maria Kefalas

Medicaid covers sick or dying children. But it takes ‘going to battle’ to get it

First Opinion By Ira Byock and Eric Walsh

Hopewell House hospice has closed. You should care about that

Politics By Priyanka Dayal McCluskey — Boston Globe and Matt Stout — Boston Globe

Mass. governor — and one-time insurance executive — eyes a legacy-defining revamp of state’s health care

Pharmalot By Ed Silverman

Pharmalittle: Five companies offer $50 billion deal to settle opioid suits; FDA approves record number of generics